<?xml version="1.0"?><root><issue><title Title="Issue xml" direction="ltr">International Journal of Endocrinology and Metabolism</title><title_fa Title="Title_fa">مجله‌ي بین المللی غدد درون‌ريز و متابوليسم</title_fa><short_title Title="Short_title">Int J Endocrinol Metab</short_title><subject Title="Subject">Medical Sciences</subject><web_url Title="Web_url">http://www.ijem.org</web_url><journal_hbi_system_id Title="Journal_hbi_system_id"></journal_hbi_system_id><journal_hbi_system_user Title="Journal_hbi_system_user"></journal_hbi_system_user><journal_id_issn Title="Journal_id_issn">1726-913X</journal_id_issn><journal_id_issn_online Title="Journal_id_issn_online"></journal_id_issn_online><journal_id_pii Title="Journal_id_pii"></journal_id_pii><journal_id_doi Title="Journal_id_doi"></journal_id_doi><journal_id_iranmedex Title="Journal_id_iranmedex"></journal_id_iranmedex><journal_id_magiran Title="Journal_id_magiran"></journal_id_magiran><journal_id_sid Title="Journal_id_sid"></journal_id_sid><journal_id_nlai Title="Journal_id_nlai"></journal_id_nlai><journal_id_science Title="Journal_id_science"></journal_id_science><language Title="Language">en</language><article><article_id_issn_online Title="Article_id_issn_online"></article_id_issn_online><article_id_pubmed Title="Article_id_pubmed"></article_id_pubmed><article_id_pii Title="Article_id_pii"></article_id_pii><article_id_doi Title="Article_id_doi"></article_id_doi><article_id_iranmedex Title="Article_id_iranmedex"></article_id_iranmedex><article_id_magiran Title="Article_id_magiran"></article_id_magiran><article_id_sid Title="Article_id_sid"></article_id_sid><articletitle Title="ArticleTitle">Salt Iodization, Monitoring, and Evaluation (SIME): anSalt Iodization, Monitoring, and Evaluation (SIME): anEffective Replacement for Universal Salt Iodization(USI)Effective Replacement for Universal Salt Iodization(USI)</articletitle><authors Title="Authors">Azizi F.<author><full_name>Azizi F.</full_name><suffix /><email /><code /><affiliation /></author></authors><articleinstitution Title="ArticleInstitution">Endocrine Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, I.R.Iran</articleinstitution><articlecategory Title="ArticleCategory">Editorial</articlecategory><articleabstract Title="ArticleAbstract">_</articleabstract><articlekeyword Title="ArticleKeyword">_</articlekeyword><articleruningtitle Title="ArticleRuningTitle">Salt Iodization, Monitoring, and Evaluation (SIME)</articleruningtitle><articlecorrespondence Title="ArticleCorrespondence">Fereidoun Azizi, MD. Endocrine Research Center, PO Box 4763, Tehran-19395, I.R.Iran</articlecorrespondence><articlereceivedate Title="ArticleReceiveDate">8/1/2003 12:00:00 AM</articlereceivedate><articleaccepteddate TitlePe="ArticleAcceptedDate">9/23/2003 12:00:00 AM</articleaccepteddate><articleemail Title="ArticleEmail">azizi@erc-iran.com</articleemail><articleissuenumber Title="ArticleIssueNumber">2</articleissuenumber><articlestartpage Title="ArticleStartPage">46</articlestartpage><articleendpage Title="ArticleEndPage">47</articleendpage><artweb_url Title="Artweb_url">http://www.ijem.org/Default.aspx</artweb_url></article><articlevolumenumber Title="ArticleVolumeNumber">1</articlevolumenumber><article><article_id_issn_online Title="Article_id_issn_online"></article_id_issn_online><article_id_pubmed Title="Article_id_pubmed"></article_id_pubmed><article_id_pii Title="Article_id_pii"></article_id_pii><article_id_doi Title="Article_id_doi"></article_id_doi><article_id_iranmedex Title="Article_id_iranmedex"></article_id_iranmedex><article_id_magiran Title="Article_id_magiran"></article_id_magiran><article_id_sid Title="Article_id_sid"></article_id_sid><articletitle Title="ArticleTitle">A Preventive Trial of Short-Term Immunosuppressive Therapy in Postpartum Thyroid Dysfunction</articletitle><authors Title="Authors">Tada H, Hidaka Y, Izumi Y, Takano T, Nakata Y, Tatsumi K, Amino N.<author><full_name>Tada H</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Hidaka Y</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Izumi Y</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Takano T</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Nakata Y</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Tatsumi K</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Amino N.</full_name><suffix /><email /><code /><affiliation /></author></authors><articleinstitution Title="ArticleInstitution">Department of Laboratory Medicine, Osaka University Graduate School of Medicine, Osaka,&lt;br&gt;Japan</articleinstitution><articlecategory Title="ArticleCategory">Original Article</articlecategory><articleabstract Title="ArticleAbstract">Autoimmune diseases, once developed,
are often hard to control and thus prevention
of disease development is obviously
of great importance. Postpartum onset of
autoimmune diseases, especially autoimmune
thyroid disease, is frequently observed and postpartum
hypothyroidism is a good candidate for investigation
of prediction and a trial of prevention
of disease development.
Materials and Methods: In order to clarify the
method of prediction of postpartum onset of hypothyroidism,
9 patients who had had previous
episodes of postpartum hypothyroidism and
high titers (more than 5 &amp;amp;#215; 103) of anti-thyroid
microsomal antibodies were examined during
the postpartum period of their current pregnancies.
Thyroid function, size of goiter and titer of
anti-microsomal antibodies were observed every
month for 12 months after delivery. The other
two patients, who were expected to develop
postpartum hypothyroidism after present parturition
and had high anti-thyroid microsomal antibody
titers of more than 5 &amp;amp;#215; 103, were treated
with short-term glucocorticoid therapy.
Results: All 9 patients, who had previous postpartum
transient hypothyroidism and had had
high anti-thyroid microsomal antibodies, developed
recurrence of postpartum hypothyroidism
at almost the same postpartum time. A shortterm
glucocorticoid therapy was tried for two
other cases who were expected to have recurrence
of postpartum hypothyroidism. In the first
case, occurrence of postpartum hypothyroidism
was delayed by 2 months and peak value of TSH
was lower than that of the previous episode. In
the second case, duration and dose of predonisolone
was doubled and development of postpartum
hypothyroidism was successfully prevented.
Conclusion: Postpartum recurrence of hypothyroidism
was predicted in patients who had previous
episodes of postpartum transient hypothyroidism
and higher titers of anti-thyroid microsomal
antibodies. The short-term predonisolone
therapy successfully prevented postpartum development</articleabstract><articlekeyword Title="ArticleKeyword">Postpartum thyroiditis, Prevention, Glucocorticoid therapy, Postpartum hypothyroidism</articlekeyword><articleruningtitle Title="ArticleRuningTitle">A Preventive Trial of Short-Term Immunosuppressive Therapy in Postpartum Thyroid Dysfunction</articleruningtitle><articlecorrespondence Title="ArticleCorrespondence">Nobuyuki Amino, Department of Laboratory Medicine, Osaka University Graduate School of Medicine, D2, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan</articlecorrespondence><articlereceivedate Title="ArticleReceiveDate">8/1/2003 12:00:00 AM</articlereceivedate><articleaccepteddate TitlePe="ArticleAcceptedDate">9/25/2003 12:00:00 AM</articleaccepteddate><articleemail Title="ArticleEmail">namino@labo.med.osaka-u.ac.jp</articleemail><articleissuenumber Title="ArticleIssueNumber">2</articleissuenumber><articlestartpage Title="ArticleStartPage">48</articlestartpage><articleendpage Title="ArticleEndPage">54</articleendpage><artweb_url Title="Artweb_url">http://www.ijem.org/Default.aspx</artweb_url></article><articlevolumenumber Title="ArticleVolumeNumber">1</articlevolumenumber><article><article_id_issn_online Title="Article_id_issn_online"></article_id_issn_online><article_id_pubmed Title="Article_id_pubmed"></article_id_pubmed><article_id_pii Title="Article_id_pii"></article_id_pii><article_id_doi Title="Article_id_doi"></article_id_doi><article_id_iranmedex Title="Article_id_iranmedex"></article_id_iranmedex><article_id_magiran Title="Article_id_magiran"></article_id_magiran><article_id_sid Title="Article_id_sid"></article_id_sid><articletitle Title="ArticleTitle">Prevalence of Overweight and Obesity and Their Relation to Hypertension in Adult Male University Students in Kerman, Iran</articletitle><authors Title="Authors">Shahbazpour N<author><full_name>Shahbazpour N</full_name><suffix /><email /><code /><affiliation /></author></authors><articleinstitution Title="ArticleInstitution">School of Physical Education and Sport Sciences, Shahid Bahonar University of Kerman, Kerman, I.R. Iran&lt;br&gt;</articleinstitution><articlecategory Title="ArticleCategory">Original Article</articlecategory><articleabstract Title="ArticleAbstract">This study examined cardiovascular risk
factors among adult male university
students in Kerman, Iran.
Materials and Methods: Study populations of
male university students, enrolled for physical
education classes during the winter of 2001, at
the Shahid Bahonar University of Kerman, were
examined and evaluated. Tthe partial correlation
coefficient was used to quantify the association
between body mass index and waist-to-hip circumference
ratio with systolic blood pressure
and diastolic blood pressure. Linear regression
analysis was used to assess the influence of body
mass index and waist-to-hip circumference ratio
on the variance of systolic blood pressure and
diastolic blood pressure.
Results: The prevalence of overweight and obesity
was 13.6% and 2.2%, respectively. 45.5% of
the subjects had normal weight and 38.4% were
underweight. 11.4% of the participants had
waist-to-hip circumference ratio (WHR) ≥ 92. We
found a positive correlation between body mass
index and waist-to-hip circumference ratio.
Stepwise linear regression analysis controlled
for age revealed that both body mass index and
waist-to-hip circumference ratio were independently
correlated with both systolic and diastolic
blood pressures.
Conclusion: The present results suggest that of
the university students studied, those with either
higher body mass index or central adiposity distribution
are potential candidates at increased
risk of hypertension and cardiovascular disease.</articleabstract><articlekeyword Title="ArticleKeyword">Overweight, obesity; body mass index, central adiposity; hypertension</articlekeyword><articleruningtitle Title="ArticleRuningTitle">Prevalence of Overweight and Obesity and Their Relation to Hypertension in Adult Male University Students in Kerman, Iran</articleruningtitle><articlecorrespondence Title="ArticleCorrespondence">Nosratollah shahbazpour; School of Physical Education and Sport Sciences, Shaheed Bahonar University of Kerman, Kerman, Iran</articlecorrespondence><articlereceivedate Title="ArticleReceiveDate">7/30/2003 12:00:00 AM</articlereceivedate><articleaccepteddate TitlePe="ArticleAcceptedDate">9/26/2003 12:00:00 AM</articleaccepteddate><articleemail Title="ArticleEmail">nshahbazpour@yahoo.com</articleemail><articleissuenumber Title="ArticleIssueNumber">2</articleissuenumber><articlestartpage Title="ArticleStartPage">55</articlestartpage><articleendpage Title="ArticleEndPage">60</articleendpage><artweb_url Title="Artweb_url">http://www.ijem.org/Default.aspx</artweb_url></article><articlevolumenumber Title="ArticleVolumeNumber">1</articlevolumenumber><article><article_id_issn_online Title="Article_id_issn_online"></article_id_issn_online><article_id_pubmed Title="Article_id_pubmed"></article_id_pubmed><article_id_pii Title="Article_id_pii"></article_id_pii><article_id_doi Title="Article_id_doi"></article_id_doi><article_id_iranmedex Title="Article_id_iranmedex"></article_id_iranmedex><article_id_magiran Title="Article_id_magiran"></article_id_magiran><article_id_sid Title="Article_id_sid"></article_id_sid><articletitle Title="ArticleTitle">The Effect of Iodized Oil Administration on the Impaired Hearing of Iodine Deficient Schoolchildren</articletitle><authors Title="Authors">Mirmiran P, Hedayati M, Noohi S, c.&lt;sup&gt;a,c&lt;/sup&gt;<author><full_name>Mirmiran P</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Hedayati M</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Noohi S</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> c.&lt;sup&gt;a</full_name><suffix /><email /><code /><affiliation /></author><author><full_name>c&lt;/sup&gt;</full_name><suffix /><email /><code /><affiliation /></author></authors><articleinstitution Title="ArticleInstitution">&lt;sup&gt;a&lt;/sup&gt;Endocrine Research Center and Departments of &lt;sup&gt;b&lt;/sup&gt;Otolaryngology and &lt;sup&gt;c&lt;/sup&gt;Medicine,&lt;br&gt;Taleghani Medical Center, Shaheed Beheshti University of Medical Sciences, Tehran,&lt;br&gt;I</articleinstitution><articlecategory Title="ArticleCategory">Original Article</articlecategory><articleabstract Title="ArticleAbstract">Hearing loss and auditory disturbances
may be present in both iodine deficient
and hypothyroid children. The aim of
this study was to determine the effect of iodine
supplementation on the auditory threshold in
iodine deficient children.
Materials and Methods: 54 schoolchildren of the
Kiga village, an area of severe iodine deficiency
were studied before and one and three years after
injection of 480 mg iodized oil. Goiter was
graded according to WHO classification. Serum
T4, T3, TSH and thyroglobulin concentrations
and urinary iodine levels were measured. Audiometry
was performed with a pure tone audiometer.
Results: There was a significant rise in serum T4
and significant decrease in the prevalence and
severity of large goiters, and in serum TSH and
thyroglobulin concentrations, one and three
years after intervention. Before iodine supplementation,
hearing was abnormal in 44% of
schoolchildren. Mean hearing threshold was
15.4±6.0 prior to, and decreased to 13.9±6.0 and
10.1±4.7, dB, one and 3 years after, intervention,
respectively (P&lt;0.001). Hearing thresholds above
15 dB were detected in 45, 14 and 10% of pupils
prior to, and one and 3 years after intervention,
respectively (P&lt;0.001).
Conclusion: It is concluded that iodine supplementation
improves auditory thresholds in previously
iodine deficient children.</articleabstract><articlekeyword Title="ArticleKeyword">Iodine deficiency, Hearing threshold, Auditory disturbance, Thyroid function, Iodized oil, Iodized salt</articlekeyword><articleruningtitle Title="ArticleRuningTitle">The Effect of Iodized Oil Administration on the Impaired Hearing of Iodine Deficient Schoolchildren</articleruningtitle><articlecorrespondence Title="ArticleCorrespondence">Parvin Mirmiran, Endocrine Research Center, PO Box 4763, Tehran-19395, I.R. Iran</articlecorrespondence><articlereceivedate Title="ArticleReceiveDate">8/31/2003 12:00:00 AM</articlereceivedate><articleaccepteddate TitlePe="ArticleAcceptedDate">9/28/2003 12:00:00 AM</articleaccepteddate><articleemail Title="ArticleEmail">mirmiran@erc-iran.com</articleemail><articleissuenumber Title="ArticleIssueNumber">2</articleissuenumber><articlestartpage Title="ArticleStartPage">61</articlestartpage><articleendpage Title="ArticleEndPage">66</articleendpage><artweb_url Title="Artweb_url">http://www.ijem.org/Default.aspx</artweb_url></article><articlevolumenumber Title="ArticleVolumeNumber">1</articlevolumenumber><article><article_id_issn_online Title="Article_id_issn_online"></article_id_issn_online><article_id_pubmed Title="Article_id_pubmed"></article_id_pubmed><article_id_pii Title="Article_id_pii"></article_id_pii><article_id_doi Title="Article_id_doi"></article_id_doi><article_id_iranmedex Title="Article_id_iranmedex"></article_id_iranmedex><article_id_magiran Title="Article_id_magiran"></article_id_magiran><article_id_sid Title="Article_id_sid"></article_id_sid><articletitle Title="ArticleTitle">The Influence of Supplemental Vitamin C on Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus</articletitle><authors Title="Authors">Forghani B, Goharian V, Kasaeeian N, Amini M.<author><full_name>Forghani B</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Goharian V</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Kasaeeian N</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Amini M.</full_name><suffix /><email /><code /><affiliation /></author></authors><articleinstitution Title="ArticleInstitution">Endocrine Research Center, Isfahan University of Medical Sciences and Health Services, Isfahan, I.R.Iran</articleinstitution><articlecategory Title="ArticleCategory">Original Article</articlecategory><articleabstract Title="ArticleAbstract">There is evidence implying the influence
of vitamin C on prevention of hemoglobin
glycation. The aim of the present
study was to investigate the effect
of vitamin C on the level of glycosylated hemoglobin
(HbA1c) in patients with type 2-diabetes.
Materials and Methods: 18 patients with type 2
diabetes (14 females, 4 males) were enrolled in a
clinical trial study. 1000 mg of supplemental vitamin
C (divided into 4 doses) per day was given
to the subjects for 6 weeks. Body mass index
(BMI), a 3-day diet recall, fasting plasma glucose
and glycosylated hemoglobin were measured before
and after the administration of supplemental
vitamin C. Data were analyzed by paired ttest.
Results: Body weight and BMI were slightly
higher at the end of study, as compared to before.
Glycosylated hemoglobin level decreased
significantly at the end of study 11.8±1.48 vs,
10.2±1.28%, (p&lt;0.015). Fasting plasma glucose did
not change.
Conclusion: Our findings indicate that vitamin C
as a result of its structural similarity to glucose
can compete with it to reduce hemoglobin glycosylation
in patients with type 2-diabetes.</articleabstract><articlekeyword Title="ArticleKeyword">Diabetes mellitus, Vitamin C, Fasting blood glucose, Glycosylated hemoglobin, Body mass index</articlekeyword><articleruningtitle Title="ArticleRuningTitle">The Influence of Supplemental Vitamin C on Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus</articleruningtitle><articlecorrespondence Title="ArticleCorrespondence">Badrolmoluk Forghani, Endocrine Research Center, Isfahan University of Medical Sciences and Health Services, Isfahn, I.R.Iran</articlecorrespondence><articlereceivedate Title="ArticleReceiveDate">9/1/2003 12:00:00 AM</articlereceivedate><articleaccepteddate TitlePe="ArticleAcceptedDate">9/29/2003 12:00:00 AM</articleaccepteddate><articleemail Title="ArticleEmail">_</articleemail><articleissuenumber Title="ArticleIssueNumber">2</articleissuenumber><articlestartpage Title="ArticleStartPage">67</articlestartpage><articleendpage Title="ArticleEndPage">70</articleendpage><artweb_url Title="Artweb_url">http://www.ijem.org/Default.aspx</artweb_url></article><articlevolumenumber Title="ArticleVolumeNumber">1</articlevolumenumber><article><article_id_issn_online Title="Article_id_issn_online"></article_id_issn_online><article_id_pubmed Title="Article_id_pubmed"></article_id_pubmed><article_id_pii Title="Article_id_pii"></article_id_pii><article_id_doi Title="Article_id_doi"></article_id_doi><article_id_iranmedex Title="Article_id_iranmedex"></article_id_iranmedex><article_id_magiran Title="Article_id_magiran"></article_id_magiran><article_id_sid Title="Article_id_sid"></article_id_sid><articletitle Title="ArticleTitle">Current State of Growth Hormone Therapy</articletitle><authors Title="Authors">Mohammadian S, Sadeghi-Nejad A.<author><full_name>Mohammadian S</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Sadeghi-Nejad A.</full_name><suffix /><email /><code /><affiliation /></author></authors><articleinstitution Title="ArticleInstitution">&lt;sup&gt;a&lt;/sup&gt; Department of Pediatrics, Golestan University of Medical Sciences, Gorgan, I.R.Iran&lt;br&gt;&lt;sup&gt;b&lt;/sup&gt; Division of Pediatric Endocrinology and Metabolism, Tufts University School of Medicine</articleinstitution><articlecategory Title="ArticleCategory">Review Article</articlecategory><articleabstract Title="ArticleAbstract">Biosynthetic growth hormone is now
available in virtually unlimited quantities.
As a result, because of its growth
promoting and anabolic effects, it is
widely used in various disorders in both children
and adults. Growth hormone has been
proven to be beneficial in a small number of diseases
causing short stature in children, and in
adults with severe growth hormone deficiency or
acquired immunodeficiency syndrome (AIDS).
The hormone is also used on an investigational
basis in a variety of disorders causing short stature,
as well as in the aged and in several catabolic
conditions. It is likely that with time the
indications for treatment with this hormone will
increase.</articleabstract><articlekeyword Title="ArticleKeyword">Growh hormone, Treatment Complications</articlekeyword><articleruningtitle Title="ArticleRuningTitle">Current State of Growth Hormone Therapy</articleruningtitle><articlecorrespondence Title="ArticleCorrespondence">Abdollah Sadeghi-Nejad, M.D. Tufts-New England Medical Center. Box 346, 750 Washington Street Boston, MA 02111</articlecorrespondence><articlereceivedate Title="ArticleReceiveDate">7/17/2003 12:00:00 AM</articlereceivedate><articleaccepteddate TitlePe="ArticleAcceptedDate">9/26/2003 12:00:00 AM</articleaccepteddate><articleemail Title="ArticleEmail">asadeghi@lifespan.org</articleemail><articleissuenumber Title="ArticleIssueNumber">2</articleissuenumber><articlestartpage Title="ArticleStartPage">71</articlestartpage><articleendpage Title="ArticleEndPage">83</articleendpage><artweb_url Title="Artweb_url">http://www.ijem.org/Default.aspx</artweb_url></article><articlevolumenumber Title="ArticleVolumeNumber">1</articlevolumenumber><article><article_id_issn_online Title="Article_id_issn_online"></article_id_issn_online><article_id_pubmed Title="Article_id_pubmed"></article_id_pubmed><article_id_pii Title="Article_id_pii"></article_id_pii><article_id_doi Title="Article_id_doi"></article_id_doi><article_id_iranmedex Title="Article_id_iranmedex"></article_id_iranmedex><article_id_magiran Title="Article_id_magiran"></article_id_magiran><article_id_sid Title="Article_id_sid"></article_id_sid><articletitle Title="ArticleTitle">Testosterone: An Overview; Insights into its Physiology and Clinical Implications</articletitle><authors Title="Authors">Celec P, Ostatníková D.<author><full_name>Celec P</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Ostatníková D.</full_name><suffix /><email /><code /><affiliation /></author></authors><articleinstitution Title="ArticleInstitution">&lt;sup&gt;a&lt;/sup&gt; Faculty of Medicine, and &lt;sup&gt;b&lt;/sup&gt; Faculty of Natural Sciences, Comenius University, Bratislava,&lt;br&gt;Slovakia</articleinstitution><articlecategory Title="ArticleCategory">Review Article</articlecategory><articleabstract Title="ArticleAbstract">Latest advances in the scientific research
of testosterone reflected by a high
number of recent publications make it
necessary to summarize the findings in this review.
Both in vitro and in vivo studies have shed
light especially on the complex net of intracrinological
interactions, testosterone kinetics on
cellular level and its recognition by a wide spectrum
of nuclear, cytoplasmatic and membranebound
receptors. This recently accumulated
knowledge has important pathophysiological
and clinical implications. Apart from androgendependent
cancers, infertility therapy, cardiovascular
diseases and ageing are also among the
fields of biomedical investigation where testosterone
plays a crucial role. Future studies will
further facilitate both, basic research and clinical
medicine and uncover the secrets of cognitive effects
and chronobiology of testosterone.</articleabstract><articlekeyword Title="ArticleKeyword">Testosterone, Androgen receptor, Contraception, Hormone replacement, Hormonedependent tumours, Intracrinology</articlekeyword><articleruningtitle Title="ArticleRuningTitle">Testosterone: An Overview; Insights into its Physiology and Clinical Implications</articleruningtitle><articlecorrespondence Title="ArticleCorrespondence">Peter Celec, Galbavého 3, 841 01 Bratislava, Slovakia</articlecorrespondence><articlereceivedate Title="ArticleReceiveDate">7/8/2003 12:00:00 AM</articlereceivedate><articleaccepteddate TitlePe="ArticleAcceptedDate">9/9/2003 12:00:00 AM</articleaccepteddate><articleemail Title="ArticleEmail">petercelec@hotmail.com</articleemail><articleissuenumber Title="ArticleIssueNumber">2</articleissuenumber><articlestartpage Title="ArticleStartPage">84</articlestartpage><articleendpage Title="ArticleEndPage">96</articleendpage><artweb_url Title="Artweb_url">http://www.ijem.org/Default.aspx</artweb_url></article><articlevolumenumber Title="ArticleVolumeNumber">1</articlevolumenumber><article><article_id_issn_online Title="Article_id_issn_online"></article_id_issn_online><article_id_pubmed Title="Article_id_pubmed"></article_id_pubmed><article_id_pii Title="Article_id_pii"></article_id_pii><article_id_doi Title="Article_id_doi"></article_id_doi><article_id_iranmedex Title="Article_id_iranmedex"></article_id_iranmedex><article_id_magiran Title="Article_id_magiran"></article_id_magiran><article_id_sid Title="Article_id_sid"></article_id_sid><articletitle Title="ArticleTitle">True Precocious Puberty Following Removal of Virilizing Adrenal Tumor</articletitle><authors Title="Authors">Rashaud A, Najafizadeh M.<author><full_name>Rashaud A</full_name><suffix /><email /><code /><affiliation /></author><author><full_name> Najafizadeh M.</full_name><suffix /><email /><code /><affiliation /></author></authors><articleinstitution Title="ArticleInstitution">Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran,I.R.Iran</articleinstitution><articlecategory Title="ArticleCategory">Case Report</articlecategory><articleabstract Title="ArticleAbstract">Adrenal tumors are rare in children.
Most of these tumors are virilizing. We
present here the report of a girl with
childhood virilization due to adrenal
tumor in early childhood. In this patient after
tumor resection and regression of secondary
male sex characteristics, signs of secondary female
sex characteristics developed before the age
of 8 years due to pituitary activation (true precocious
puberty). Treatment was performed with a
GnRH analogue. Virilizing adrenal tumors have
not been included in the etiology of true precocious
puberty. It is suggested to consider these
tumors as one of the causes of true precocious
puberty.</articleabstract><articlekeyword Title="ArticleKeyword">True precocious puberty, Virilizing, Adrenal tumor</articlekeyword><articleruningtitle Title="ArticleRuningTitle">True Precocious Puberty Following Removal of Virilizing Adrenal Tumor</articleruningtitle><articlecorrespondence Title="ArticleCorrespondence">A Rashaud, 1/37 Varshow St.,South Aban Ave., Tehran, I.R. Iran</articlecorrespondence><articlereceivedate Title="ArticleReceiveDate">8/4/2003 12:00:00 AM</articlereceivedate><articleaccepteddate TitlePe="ArticleAcceptedDate">9/10/2003 12:00:00 AM</articleaccepteddate><articleemail Title="ArticleEmail">_</articleemail><articleissuenumber Title="ArticleIssueNumber">2</articleissuenumber><articlestartpage Title="ArticleStartPage">97</articlestartpage><articleendpage Title="ArticleEndPage">100</articleendpage><artweb_url Title="Artweb_url">http://www.ijem.org/Default.aspx</artweb_url></article><articlevolumenumber Title="ArticleVolumeNumber">1</articlevolumenumber></issue></root>